Fennec Pharmaceuticals In... (FENC)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

6.05

0.33%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02	FY01	FY00
Revenue	21.25M	1.53M	-	170.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.66	0.68
Cost of Revenue	1.26M	86.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-55.23K	-
Gross Profit	19.99M	1.45M	-	170.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	55.23K	0.68
Operating Income	-12.77M	-22.59M	-17.22M	-17.89M	-13.01M	-10.41M	-6.95M	-2.87M	-1.89M	-2.88M	-1.93M	-3.62M	-3.44M	-4.60M	-3.22M	-13.89M	-14.19M	-19.06M	-18.35M	-9.42M	-6.74M	-4.04M	-2.65M	-1.61M
Interest Income	441.00K	195.00K	54.00K	87.00K	322.32K	-	-	-	3.00K	2.00K	2.00K	25.00K	43.00K	32.00K	47.00K	286.00K	833.00K	-	361.00K	-	-	-	-	-
Pretax Income	-16.05M	-23.71M	-17.35M	-18.11M	-12.78M	-9.89M	-7.05M	-2.79M	-659.00K	-2.18M	1.84M	-5.16M	4.68M	-7.82M	-3.01M	-13.60M	-13.36M	-20.64M	-21.54M	-9.59M	-6.67M	-3.72M	-2.45M	-1.60M
Net Income	-16.05M	-24.84M	-17.46M	-17.92M	-12.46M	-9.89M	-7.05M	-2.79M	-659.00K	-2.18M	1.84M	-5.16M	4.68M	-7.82M	-3.01M	-13.60M	-13.36M	-19.10M	-19.25M	-8.74M	-6.15M	-3.72M	-2.45M	-1.60M
Selling & General & Admin	32.71M	20.51M	12.24M	12.95M	7.40M	5.40M	5.01M	2.40M	1.63M	2.52M	1.33M	1.54M	1.94M	3.90M	1.21M	3.52M	3.28M	2.88M	3.18M	3.49M	1.78M	907.40K	738.72K	614.25K
Research & Development	56.00K	3.53M	4.98M	5.11M	5.61M	5.01M	1.94M	472.00K	256.00K	357.00K	597.00K	2.08M	1.49M	708.00K	2.11M	10.37M	10.91M	14.00M	12.44M	3.59M	3.55M	3.13M	1.91M	939.36K
Other Expenses	-	-	-	-9.00K	-17.00K	6.00K	-8.00K	-14.00K	-	-	-3.00K	-5.00K	-	-	-	-	-	2.18M	2.72M	2.34M	1.42M	-	55.23K	52.01K
Operating Expenses	32.76M	24.04M	17.22M	18.05M	13.01M	10.41M	6.95M	2.87M	1.89M	2.88M	1.93M	3.62M	3.44M	4.60M	2.83M	13.89M	14.19M	19.06M	18.35M	9.42M	6.74M	4.04M	2.70M	1.61M
Interest Expense	3.39M	978.00K	126.00K	9.00K	-	-	-	-	-	2.00K	-	-	-	-	-	-	-	-3.00K	11.00K	-444.00K	-	-	-	-
Selling & Marketing Expenses	12.12M	2.79M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	34.02M	24.12M	17.22M	18.05M	13.01M	10.41M	6.95M	2.87M	1.89M	2.88M	1.93M	3.62M	3.44M	4.60M	2.83M	13.89M	14.19M	19.06M	18.35M	9.42M	6.74M	4.04M	2.65M	1.61M
Income Tax	-	1.13M	110.00K	-187.00K	-315.00K	-348.00K	-47.00K	-8.00K	-3.00K	-2.00K	-2.00K	-25.00K	-43.00K	7.82M	3.01M	13.60M	13.36M	-1.53M	-2.29M	-854.68K	-518.20K	3.72M	2.45M	1.60M
Shares Outstanding (Basic)	26.57M	26.27M	26.01M	23.70M	19.90M	18.94M	14.99M	12.68M	10.83M	9.87M	9.72M	8.20M	7.99M	7.08M	3.07M	3.07M	2.79M	1.14M	941.26K	580.75K	309.64K	192.51K	122.02K	536.64K
Shares Outstanding (Diluted)	26.57M	26.27M	26.01M	23.70M	19.90M	19.02M	15.01M	12.77M	10.83M	9.87M	10.57M	8.39M	8.02M	7.08M	3.07M	3.07M	2.79M	1.14M	941.26K	580.75K	309.64K	192.51K	607.09K	536.64K
EPS (Basic)	-0.6	-0.95	-0.67	-0.76	-0.63	-0.52	-0.47	-0.22	-0.06	-0.22	0.19	-0.63	0.59	-1.11	-0.98	-4.43	-4.78	-16.72	-20.45	-15.04	-19.85	-19.32	-20.12	-2.98
EPS (Diluted)	-0.6	-0.95	-0.67	-0.76	-0.63	-0.52	-0.47	-0.22	-0.06	-0.22	0.17	-0.62	0.58	-1.11	-0.98	-4.43	-4.78	-16.72	-20.45	-15.04	-19.85	-19.32	-4.04	-2.98
EBITDA	-12.36M	-22.59M	-123.00K	-17.89M	234.00K	521.00K	-95.00K	82.00K	-1.89M	-2.88M	1.79M	-5.18M	4.55M	-4.60M	-2.60M	-13.89M	-14.19M	-17.91M	-19.27M	-12.56M	-5.22M	-4.24M	-2.79M	-2.59M
Depreciation & Amortization	287.00K	149.00K	17.22M	402.00K	13.01M	10.41M	6.95M	2.87M	-1.23M	-699.00K	-1K	20.00K	43.00K	3.25M	615.00K	164.00K	192.00K	2.43M	3.06M	2.52M	1.61M	123.76K	55.23K	52.01K